Therapeutic induction of autophagy to modulate neurodegenerative disease progression

Acta Pharmacol Sin. 2013 May;34(5):600-4. doi: 10.1038/aps.2012.189. Epub 2013 Feb 4.

Abstract

There is accumulating evidence that aggregating, misfolded proteins may have an impact on autophagic function, suggesting that this could be a secondary pathological mechanism in many diseases. In this review, we focus on the role of autophagy in four major neurodegenerative diseases: Alzheimer disease (AD), Huntington's disease (HD), Parkinson's disease (PD) and amyotropic lateral sclerosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Autophagy / drug effects*
  • Central Nervous System / drug effects
  • Central Nervous System / metabolism
  • Central Nervous System / pathology*
  • Disease Progression
  • Humans
  • Molecular Targeted Therapy / methods*
  • Neurodegenerative Diseases / drug therapy*
  • Neurodegenerative Diseases / metabolism
  • Neurodegenerative Diseases / pathology*
  • Signal Transduction / drug effects
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • TOR Serine-Threonine Kinases